cetirizine and hydroxychloroquine

cetirizine has been researched along with hydroxychloroquine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Copenhaver, C; Iweala, OI; Moran, TP; Wu, EY1
Arceu, M; Carreño, L; Cortés, A; Vargas-Mora, P1
Benzecry, V; Romagnuolo, M; Veraldi, S1

Reviews

1 review(s) available for cetirizine and hydroxychloroquine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for cetirizine and hydroxychloroquine

ArticleYear
Hydroxychloroquine as a steroid-sparing agent in an infant with chronic urticaria.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2018, Volume: 120, Issue:1

    Topics: Acetates; Anti-Inflammatory Agents; Antimalarials; Cetirizine; Chronic Disease; Cyclopropanes; Diphenhydramine; Drug Resistance; Histamine Antagonists; Humans; Hydroxychloroquine; Infant; Male; Quinolines; Ranitidine; Skin; Sulfides; Urticaria

2018
Multiple annular plaques in an adult woman.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2020, Volume: 18, Issue:9

    Topics: Cetirizine; Dapsone; Eosinophilia; Erythema; Female; Humans; Hydroxychloroquine; Middle Aged; Prednisone; Skin Diseases, Genetic

2020
Urticaria as a first clinical manifestation of COVID-19.
    European journal of dermatology : EJD, 2020, Dec-01, Volume: 30, Issue:6

    Topics: Acetaminophen; Adult; Antiviral Agents; Cetirizine; COVID-19; COVID-19 Drug Treatment; Dermatologic Agents; Drug Therapy, Combination; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Hydroxychloroquine; Male; Middle Aged; SARS-CoV-2; Urticaria

2020